Status:
COMPLETED
Impact of a One-month Long Detoxification Diazepam Treatment on Early Alcohol Relapse
Lead Sponsor:
University Hospital, Lille
Conditions:
Alcoholism
Eligibility:
All Genders
18-60 years
Phase:
NA
Brief Summary
Alcohol-dependence is a medical condition that can lead to the occurrence of an alcohol withdrawal syndrome (AWS) in case of alcohol drinking cessation. Diazepam is the reference medication for preven...
Detailed Description
* inclusion at Day 5 of the outpatient alcohol detoxification procedure * randomization in two arms: 1) "10 day - diazepam"; and 2) "30 day - diazepam" * tapering of diazepam over the 10 days followin...
Eligibility Criteria
Inclusion
- DSM-IV-Tr criteria for alcohol dependence
- Diazepam-based outpatient detoxification procedure started 5 days prior to inclusion
Exclusion
- contraindication for outpatient detoxification
- occurrence of delirium tremens or seizures during the pre-inclusion period
- contraindication for using diazepam
- any other DSM-IV-TR criteria for substance abuse or dependence in the preceding year (except from tobacco)
- concurrent axis-I psychiatric disorder
- concurrent neurological pathology or cognitive impairment
- concurrent social risk, i.e., homelessness or social isolation
- liver failure, cancer, or significant breathing disorder
Key Trial Info
Start Date :
July 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2016
Estimated Enrollment :
26 Patients enrolled
Trial Details
Trial ID
NCT02242955
Start Date
July 1 2014
End Date
July 1 2016
Last Update
September 15 2016
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Addiction Medicine
Lille, France, 59037
2
Outpatient Addiction Center "CSAPA - Le Pari"
Lille, France, 59037